Psychedelics Weekly – Research Explained...

Jen Davenport joins Psychedelics Today to interview co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with psychedelic ideas. Davenport is the founder of Iron Thread Partners and a graduat ... Show More

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psyched ... Show More

Enamory is a clinical practice, training institute, and nonprofit research organization focused on psychedelic assisted couples therapy. In this episode, clinical psychologists Chandra Kian and Kayla Knopp discuss their work integrating ketamine assisted psychotherapy with eviden ... Show More

<p>Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treat ... Show More

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ... Show More

We’re in the midst of a psychedelic renaissance, where this once demonized class of drugs is now front and center receiving attention among entrepreneurs, investors, clinical trials and even patients. In this special conversation, TED Health’s Dr. Shoshana Ungerleider speaks with ... Show More

Dr. Paul Liknaitsky is the head of clinical psychedelic research at Monash University Australia. He is conducting world-first clinical trials into the use of magic mushrooms and ecstasy to treat depression, anxiety, and PTSD. This is his second time on this podcast to chat about ... Show More

In this episode, my guest is Robin Carhart-Harris, PhD, distinguished professor of neurology and psychiatry at the University of California, San Francisco. He is one of leading researchers in the study of how psychedelics such as psilocybin, LSD and DMT can change the human brain ... Show More

<p><span style="font-weight: 400;">Sam Harris speaks with James Fadiman about the psychedelic experience. They discuss who should and shouldn't take psychedelics, set and setting, the role of a guide, the effects of microdosing, the difference between MDMA and true psychedelics, ... Show More

The idea of using psychedelics to treat psychiatric symptoms has been approaching mainstream popularity thanks to podcasters like Joe Rogan, Tim Ferris, and Sam Harris. As interest in these substances continues to grow, so does the size of the online communities centered around t ... Show More

In just a few years, psychedelics have gone from being a symbol of the 1960s counterculture to being touted as highly promising mental health treatments. Dr. Albert Garcia-Romeu, PhD, of Johns Hopkins University, talks about whether the research backs up the hype; the state of ps ... Show More

<p>How does the neuroscience of attention affect nearly every aspect of our capacity to live good lives? How can we harness tech as a tool to help our brains be more, rather than less present and aware? What do psychedelics and neuroscience have to do with each other, and how mig ... Show More